Company Filing History:
Years Active: 2019
Title: Francesca Mandrelli: Innovator in Chemical Synthesis
Introduction
Francesca Mandrelli is a notable inventor based in San Giustino, Italy. She has made significant contributions to the field of chemical synthesis, particularly in the development of neprilysin (NEP) inhibitors. Her work is essential in advancing medical treatments and improving patient outcomes.
Latest Patents
Francesca holds 1 patent for her invention titled "Process and intermediates for the preparation of NEP inhibitors." This invention relates to a new chemical synthesis, intermediates, and catalysts useful for the preparation of the NEP inhibitor sacubitril. It also includes new intermediate compounds and their applications in this innovative chemical synthesis route.
Career Highlights
Francesca is currently employed at Novartis AG, a leading global healthcare company. Her role involves research and development in the pharmaceutical sector, where she applies her expertise in chemical synthesis to create effective therapeutic solutions.
Collaborations
Throughout her career, Francesca has collaborated with talented professionals, including Benjamin Martin and Francesco Venturoni. These partnerships have enhanced her research and contributed to the success of her projects.
Conclusion
Francesca Mandrelli is a pioneering inventor whose work in chemical synthesis has the potential to impact the pharmaceutical industry significantly. Her innovative approach to developing NEP inhibitors showcases her dedication to advancing medical science.